Identifying the genetic basis of variably protease-sensitive prionopathy
Identifying the genetic basis of variably protease-sensitive prionopathy
批准号:
10448659
负责人:
Eric Vallabh Minikel
金额:
$6.68万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-02-01 至 2023-01-31
关键词:
AgeAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAutopsyBiological MarkersBiologyCerebrospinal FluidCessation of lifeClinicalCodeDNADatabasesDementiaDementia with Lewy BodiesDepositionDifferential DiagnosisDiseaseDrug TargetingElectroencephalographyFamilyFamily history ofFrequenciesFrontotemporal Lobar DegenerationsGeneticGenetic DiseasesGenomeGenomicsImpaired cognitionLeadLewy Body DementiaLifeLightLinkMethodsMutationNerve DegenerationNeurodegenerative DisordersPathologyPathway interactionsPatientsPenetrancePeptide HydrolasesPopulationPrPPrP genePrion DiseasesRecording of previous eventsReportingRouteSamplingSpeechTechnologyTestingUntranslated RNAValidationVariantcausal variantcohortexome sequencinggenetic variantgenome-wideimprovedinsightinternal controlneuroimagingnovelprotein aggregationpsychiatric symptomsuccesstargeted sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
First characterized one decade ago, VPSPr is a rare neurodegenerative disease that presents clinically as
Lewy body dementia or frontotemporal lobar degeneration but has been neuropathologically linked to deposits
of infectious but protease-sensitive prion protein (PrP) aggregates. VPSPr cases lack mutations in the prion
protein gene (PRNP) but 42% of cases have a positive family history, consistent with a genetic disease of
moderate penetrance. We will apply whole exome sequencing and deep targeted sequencing to query the
genetic basis of VPSPr. Identification of a genetic cause of VPSPr will aid in the differential diagnosis of prion
disease and Alzheimer’s-related dementias, validate new genomic technologies for understanding
neurodegeneration, and identify new cellular pathways that lead to neurodegenerative disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Advancement of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
-
批准号:10721465
-
项目类别:
-
资助金额:$80.05万
-
财政年份:2023
-
负责人:Eric Vallabh Minikel
-
依托单位:
Research Project 3
-
批准号:10669496
-
项目类别:
-
资助金额:$102.9万
-
财政年份:2023
-
负责人:Eric Vallabh Minikel
-
依托单位:
Research Project 2
-
批准号:10669495
-
项目类别:
-
资助金额:$75.63万
-
财政年份:2023
-
负责人:Eric Vallabh Minikel
-
依托单位:
Development of Prion Protein-Lowering Divalent siRNA Therapy for Prion Disease
-
批准号:10549815
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2021
-
负责人:Eric Vallabh Minikel
-
依托单位:
海外基金